You are here

Family-owned drug factories in India eroding US generic prices

Deep discounts offered by new Indian players to gain market share force incumbent players to match them

Sun Pharma and Dr Reddy's Laboratories Ltd have a backlog of applications that have been held up by US regulatory troubles which could start flowing if their factories get clearance from regulators.


THE most recent earnings reports across the generic drug industry have read like dispatches from the front lines of a price war.

This month, the world's largest copycat drugmaker, Israel's Teva Pharmaceutical Industries Ltd, slashed its dividend; US giant Mylan NV lowered...